Safety of Drug-Eluting Beads Chemoembolization in Patients with Pre-Exisiting Transjugular Intrahepatic Portosystemic Shunt




Rief, Katherine M.

Journal Title

Journal ISSN

Volume Title



STUDY AIM: To assess the safety of transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (HCC) in patients with a pre-existing transjugular intrahepatic portosystemic shunt (TIPS). METHODS: A multi-institutional, IRB approved, retrospective review was conducted of patients with a pre-existing patent TIPS who underwent TACE to treat unresectable HCC between 2009 and 2014. Patients (7 male, 4 female) ranging from 39 to 74 years of age (mean 61, SD 11) were included. Parameters of interest included type of TACE (drug-eluting beads or traditional), number of TACE procedures, 30-day mortality from last TACE procedure, and any complications or toxicity following TACE. RESULTS:Ten of the eleven patients underwent super-selective drug-eluting bead TACE, using doxorubicin at a dosage ranging from 50mg to 150mg (Median 100mg). Number of TACE procedures per patient ranged from 1 to 4 (Median 1). Three of the patients (3/11, 27%) experienced toxicity (CTAE v4) grade 2 or higher immediately following the TACE procedure. Two of these patients experienced Grade 2 Albumin Toxicity. Another had Grade 3 Toxicity of AST, ALT and bilirubin. 73% of patients were discharged within 24 hours. The remaining 3 patients were hospitalized for pain, edema, or acute pancreatitis for 3, 5 and 20 days respectively. All eleven patients were alive and discharged from the hospital 30 days after the most recent TACE procedure. DISCUSSION: TACE can be well tolerated by patients with a patent TIPS given adequate liver function. As additional cases are performed we hope to clarify the efficacy and most appropriate TIPS patient population for TACE.

General Notes

The 53rd Annual Medical Student Research Forum at UT Southwestern Medical Center (Monday, January 26, 2015, 2-5 p.m., D1.602)

Table of Contents


Rief, K., Pirasteh, A., Shenoy-Bhangle, A., Ganguli, S., & Kalva, S. (2015, January 26). Safety of drug-eluting beads chemoembolization in patients with pre-exisiting transjugular intrahepatic portosystemic shunt. Poster presented at the 53rd Annual Medical Student Research Forum, Dallas, TX. Retrieved from

Related URI